223 related articles for article (PubMed ID: 25573878)
21. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
23. Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study.
Beyan H; Riese H; Hawa MI; Beretta G; Davidson HW; Hutton JC; Burger H; Schlosser M; Snieder H; Boehm BO; Leslie RD
Diabetes; 2012 May; 61(5):1192-8. PubMed ID: 22396204
[TBL] [Abstract][Full Text] [Related]
24. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.
Jiao L; Weinstein SJ; Albanes D; Taylor PR; Graubard BI; Virtamo J; Stolzenberg-Solomon RZ
Cancer Res; 2011 May; 71(10):3582-9. PubMed ID: 21540233
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
26. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women.
Semba RD; Ferrucci L; Fink JC; Sun K; Beck J; Dalal M; Guralnik JM; Fried LP
Am J Kidney Dis; 2009 Jan; 53(1):51-8. PubMed ID: 18789567
[TBL] [Abstract][Full Text] [Related]
27. Soluble receptor for advanced glycation end products and risk of liver cancer.
Moy KA; Jiao L; Freedman ND; Weinstein SJ; Sinha R; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Hepatology; 2013 Jun; 57(6):2338-45. PubMed ID: 23325627
[TBL] [Abstract][Full Text] [Related]
28. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.
Gopal P; Rutten EP; Dentener MA; Wouters EF; Reynaert NL
Eur J Clin Invest; 2012 Aug; 42(8):807-14. PubMed ID: 22288943
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the receptor for advanced glycation end products in liver transplantation.
Navarra T; De Simone P; Del Turco S; Filipponi F; Basta G
Ann Hepatol; 2015; 14(2):190-7. PubMed ID: 25671828
[TBL] [Abstract][Full Text] [Related]
30. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
31. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Willemsen S; Hartog JW; van Veldhuisen DJ; van der Meer P; Roze JF; Jaarsma T; Schalkwijk C; van der Horst IC; Hillege HL; Voors AA
Am Heart J; 2012 Nov; 164(5):742-749.e3. PubMed ID: 23137505
[TBL] [Abstract][Full Text] [Related]
32. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
33. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
[TBL] [Abstract][Full Text] [Related]
34. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
35. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
[TBL] [Abstract][Full Text] [Related]
36. Association of the receptor for advanced glycation end products (RAGE) -374 T/A gene polymorphism and circulating soluble RAGE with nephropathy in type 1 diabetic patients.
Abdel-Azeez HA; El-Okely AM
Egypt J Immunol; 2009; 16(1):95-106. PubMed ID: 20726326
[TBL] [Abstract][Full Text] [Related]
37. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
[TBL] [Abstract][Full Text] [Related]
38. Severity of diabetic microvascular complications is associated with a low soluble RAGE level.
Grossin N; Wautier MP; Meas T; Guillausseau PJ; Massin P; Wautier JL
Diabetes Metab; 2008 Sep; 34(4 Pt 1):392-5. PubMed ID: 18701333
[TBL] [Abstract][Full Text] [Related]
39. Association of sVAP-1, sRAGE, and CML with lactation-induced insulin sensitivity in young non-diabetic healthy women.
Klenovicsová K; Krivošíková Z; Gajdoš M; Sebeková K
Clin Chim Acta; 2011 Sep; 412(19-20):1842-7. PubMed ID: 21718692
[TBL] [Abstract][Full Text] [Related]
40. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children.
Sadeharju K; Lönnrot M; Kimpimäki T; Savola K; Erkkilä S; Kalliokoski T; Savolainen P; Koskela P; Ilonen J; Simell O; Knip M; Hyöty H
Diabetologia; 2001 Jul; 44(7):818-23. PubMed ID: 11508265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
